Use of Run-in Periods in Randomized Trials
This JAMA Guide to Statistics and Methods reviews the use of prerandomization run-in periods to improve treatment adherence and reduce loss to follow-up, and explains how they should be interpreted.
This JAMA Guide to Statistics and Methods reviews the use of prerandomization run-in periods to improve treatment adherence and reduce loss to follow-up, and explains how they should be interpreted.
This Teachable Moment discusses providing patients with an opportunity to initiate dietary change before prescribing statin therapy for even severely high low-density lipoprotein cholesterol levels.
Cette année, pour la fête des mères, on se tourne vers des idées cadeaux savoureuses. Idéales pour être partagées, ces créations gourmandes feront plaisir à…
Register Now for ASNC2024 and Join Us in Austin, Texas, USA, from Sept. 5-7! You are invited to join us for the 29th Annual Scientific Session and…
🙏Srimad Bhagavad Gita Chapter 14 Verse 23🙏A man who is beyond qualities does not make any effort on his own, being situated in his soul🙏Hare…
Randomized clinical trials (RCTs) define the efficacy of new cancer treatments and drive changes in clinical practice. Although the role of RCTs in generating knowledge…
Despite a greater CAC increase with high dose and long-term statin therapy, events did not occur more frequently in statin treated patients. This suggests that…
This systematic review and meta-analysis examines whether patient participation in cancer trials is associated with greater survival benefit compared with routine care.
AliveCor announced new study results backing its handheld ECG technology at Heart Rhythm Society 2024 in Boston.
We discuss recent findings from a study by Osei et al. of 28,000 participan ts from the CAC Consortium. In statins users, both the CAC…
WBAP News Radio Dallas/Fort Worth asked Cardiologist Dr. Fahmi Farah, MD to come on the air for a live interview on 5/13/24. Contact Dr. Farah:https://bentle…